TBP

Tetra Bio Pharma (TBP)

Tetra Bio Pharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:TBP

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/03/07	22 : 01	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - TBP	TSX:TBP	Tetra Bio Pharma Inc
2023/03/07	21 : 59	PR Newswire (Canada)	IIROC Trading Halt - TBP	TSX:TBP	Tetra Bio Pharma Inc
2023/02/11	08 : 27	PR Newswire (Canada)	Tetra Bio-Pharma Announces Listing to OTCPink Market	TSX:TBP	Tetra Bio Pharma Inc
2023/02/11	08 : 27	PR Newswire (US)	Tetra Bio-Pharma Announces Listing to OTCPink Market	TSX:TBP	Tetra Bio Pharma Inc
2022/12/22	21 : 41	PR Newswire (Canada)	REDUVO™ Marketing Approval on the Right Path	TSX:TBP	Tetra Bio Pharma Inc
2022/12/22	21 : 41	PR Newswire (US)	REDUVO™ Marketing Approval on the Right Path	TSX:TBP	Tetra Bio Pharma Inc
2022/12/06	21 : 00	PR Newswire (US)	Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir	TSX:TBP	Tetra Bio Pharma Inc
2022/12/06	21 : 00	PR Newswire (Canada)	Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir	TSX:TBP	Tetra Bio Pharma Inc
2022/11/29	21 : 00	PR Newswire (US)	Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003	TSX:TBP	Tetra Bio Pharma Inc
2022/11/29	21 : 00	PR Newswire (Canada)	Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003	TSX:TBP	Tetra Bio Pharma Inc
2022/11/19	02 : 23	PR Newswire (Canada)	Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission	TSX:TBP	Tetra Bio Pharma Inc
2022/11/19	02 : 23	PR Newswire (US)	Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission	TSX:TBP	Tetra Bio Pharma Inc
2022/10/28	02 : 57	PR Newswire (US)	Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean	TSX:TBP	Tetra Bio Pharma Inc
2022/10/28	02 : 57	PR Newswire (Canada)	Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean	TSX:TBP	Tetra Bio Pharma Inc
2022/10/11	20 : 42	PR Newswire (US)	Tetra and Prepaire Jointly Apply to BARDA for Funding	TSX:TBP	Tetra Bio Pharma Inc
2022/10/11	20 : 42	PR Newswire (Canada)	Tetra and Prepaire Jointly Apply to BARDA for Funding	TSX:TBP	Tetra Bio Pharma Inc
2022/09/08	20 : 44	PR Newswire (Canada)	Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean	TSX:TBP	Tetra Bio Pharma Inc
2022/09/08	20 : 44	PR Newswire (US)	Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean	TSX:TBP	Tetra Bio Pharma Inc
2022/09/06	22 : 28	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - TBP	TSX:TBP	Tetra Bio Pharma Inc
2022/09/06	22 : 27	PR Newswire (Canada)	IIROC Trade Resumption - TBP	TSX:TBP	Tetra Bio Pharma Inc
2022/09/06	22 : 13	PR Newswire (Canada)	Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients	TSX:TBP	Tetra Bio Pharma Inc
2022/09/06	22 : 13	PR Newswire (US)	Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients	TSX:TBP	Tetra Bio Pharma Inc
2022/09/06	21 : 43	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - TBP	TSX:TBP	Tetra Bio Pharma Inc
2022/09/06	21 : 41	PR Newswire (Canada)	IIROC Trading Halt - TBP	TSX:TBP	Tetra Bio Pharma Inc
2022/08/12	11 : 19	PR Newswire (US)	Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean	TSX:TBP	Tetra Bio Pharma Inc
2022/08/12	11 : 19	PR Newswire (Canada)	Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean	TSX:TBP	Tetra Bio Pharma Inc
2022/08/10	19 : 30	PR Newswire (Canada)	Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections	TSX:TBP	Tetra Bio Pharma Inc
2022/08/10	19 : 30	PR Newswire (US)	Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections	TSX:TBP	Tetra Bio Pharma Inc
2022/07/12	20 : 30	PR Newswire (Canada)	Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug	TSX:TBP	Tetra Bio Pharma Inc
2022/07/12	20 : 30	PR Newswire (US)	Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug	TSX:TBP	Tetra Bio Pharma Inc